Kevin Hern: “It is time for us to get this resolved and fix this issue once and for all for the American people.”

One way to do this is by reducing the regulatory burden so that Title IV-B funding recipients can spend more time helping children and families, and less time waiting through the red tape.

It is critical that we keep innovation here in the U.S., but it is also critical that we make sure healthcare is affordable.

I will always advocate for those who are suffering from a rare disease and support efforts to bring treatments for these diseases to market.

It’s what the president got elected on.